Starling Oncology STLN
NASDAQ STLN
$5.95 -0.14 (-2.22%)
As of: Sep 3, 2026 · 3:37 PM EDT

Starling Oncology (STLN) Common Equity (2019 - 2026)

Analysis

Starling Oncology (STLN) Common Equity (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 HCA Healthcare 90.73 Bn 89.71 Bn 15.19 Bn -6.64 Bn
2 Tenet Healthcare 22.05 Bn 19.88 Bn 4.45 Bn 6.56 Bn
3 Encompass Health 12.13 Bn 12.00 Bn 1.34 Bn 3.40 Bn
4 Davita 11.78 Bn 11.09 Bn 1.16 Bn -765.10 Mn
5 Universal Health Services 10.12 Bn 9.98 Bn 3.29 Bn 7.58 Bn
6 Ensign 9.97 Bn 9.64 Bn 306.24 Mn 2.45 Bn
7 Chemed 6.91 Bn 6.87 Bn 221.47 Mn 830.51 Mn
8 Pacs 6.73 Bn 6.57 Bn 338.46 Mn 1.12 Bn
9 Concentra Group Holdings Parent 4.30 Bn 4.14 Bn 192.10 Mn 484.72 Mn
10 Starling Oncology 613.55 Mn 572.46 Mn 27.17 Mn -24.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -24.91 Mn
Mar 31, 2026 -16.29 Mn
Dec 31, 2025 -15.72 Mn
Sep 30, 2025 -12.27 Mn
Jun 30, 2025 -8.99 Mn
Mar 31, 2025 5.07 Mn
Dec 31, 2024 3.59 Mn
Sep 30, 2024 15.48 Mn
Jun 30, 2024 29.21 Mn
Mar 31, 2024 41.30 Mn
Dec 31, 2023 57.03 Mn
Sep 30, 2023 71.85 Mn
Jun 30, 2023 84.72 Mn
Mar 31, 2023 98.41 Mn
Dec 31, 2022 123.18 Mn
Sep 30, 2022 127.93 Mn
Jun 30, 2022 123.98 Mn
Mar 31, 2022 132.00 Mn
Dec 31, 2021 104.16 Mn
Sep 30, 2021 47.53 Mn